E Fund Management (HK)’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
CFM
DACS
GI
SS
WPA
EWA
FFA
E Fund Management (HK)'s BLTE Position: Q2 2026 in Review
E Fund Management (HK) increased its Belite Bio (BLTE) stake by 36% in Q2 2026, buying an estimated $4.6K and bringing the position to 113 shares worth $17.4K. The position accounts for 0.01% of the portfolio, ranked #344.
E Fund Management (HK) first reported a position in BLTE in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.
- E Fund Management (HK) held 113 shares of Belite Bio worth $17.4K as of Q2 2026.
- E Fund Management (HK) bought 30 Belite Bio shares in Q2 2026, an estimated $4.6K.
- Belite Bio made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #344 holding.
- E Fund Management (HK) first reported a position in Belite Bio in Q1 2026 and has held it in 2 quarters since.
- 9 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.